Biopharmaceutical co. Tvardi Therapeutics raises $74M to advance clinical pipeline, grow team
The Houston firm’s scientific advisory has ties to scientists at the M.D. Anderson Cancer Center.
Read MoreBuilding "Bridges" Across the Bayou City!
The Houston firm’s scientific advisory has ties to scientists at the M.D. Anderson Cancer Center.
Read More